{ "name": "Mobia Medical, Inc.", "legal_name": "Mobia Medical, Inc.", "ticker": "MOBI", "tickers": [ "MOBI" ], "cik": "0001489993", "page_url": "https://steadybase.io/company/mobia-medical-inc/", "markdown_url": "https://steadybase.io/company/mobia-medical-inc.md", "json_url": "https://steadybase.io/company/mobia-medical-inc.json", "as_of": "2026-11-10", "last_filed": "2026-11-05", "industry": { "sic": "3841", "description": "Surgical & Medical Instruments & Apparatus" }, "headquarters": { "city": "Austin", "state": "TX", "country": "US" }, "exchanges": [ "Nasdaq" ], "fiscal_year_end": "December 31", "filer_category": "
Emerging growth company", "state_of_incorporation": "DE", "website": "mobia.com", "investor_relations_url": "https://ir.mobia.com/", "linkedin_company_url": "https://www.linkedin.com/company/mobiamedical", "summary": { "text": "We are a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Our Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the first and only clinically-validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Stroke is one of the leading causes of long-term disability in the United States.", "section": "Item 1. Business", "period_end": "2026-05-08", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026032843/mobiamedical-424b4.htm" }, "key_facts": [ { "key": "shares_outstanding", "label": "Shares outstanding", "value": 33327912, "unit": "shares", "period_end": "2026-10-30", "form": "10-Q", "filed": "2026-11-05", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526450041/0001193125-26-450041-index.html", "text": "Shares outstanding: 33,327,912 as of Oct 30, 2026 (10-Q filed Nov 5, 2026)." } ], "metrics": {}, "next_earnings": { "date": "2026-11-10", "confidence": "unconfirmed", "webcast_url": null }, "people": [ { "name": "Richard J. Foust", "title": "President & CEO", "role": "both", "linkedin_url": null, "form": "4", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033802/0001628280-26-033802-index.htm" }, { "name": "Nelson Bunker Curnes", "title": "Chief Financial Officer", "role": "officer", "linkedin_url": null, "form": "4", "filed": "2026-06-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526268109/0001193125-26-268109-index.htm" }, { "name": "Prashant B. Rawat", "title": "Chief Operating Officer", "role": "officer", "linkedin_url": "https://linkedin.com/in/prashant-rawat-808a24", "form": "4", "filed": "2026-09-04", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526383708/0001193125-26-383708-index.htm" }, { "name": "Douglas T. Ellison", "title": "Chief Commercial Officer", "role": "officer", "linkedin_url": null, "form": "4", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033809/0001628280-26-033809-index.htm" } ], "events_8k": [ { "filed": "2026-11-05", "items": [ { "item": "2.02", "label": "Results of operations and financial condition (earnings release)", "signal": "earnings" }, { "item": "9.01", "label": "Financial statements and exhibits", "signal": "exhibits" } ], "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526449807/mobi-20261105.htm" }, { "filed": "2026-08-11", "items": [ { "item": "2.02", "label": "Results of operations and financial condition (earnings release)", "signal": "earnings" }, { "item": "9.01", "label": "Financial statements and exhibits", "signal": "exhibits" } ], "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526344666/mobi-20260811.htm" }, { "filed": "2026-08-03", "items": [ { "item": "5.02", "label": "Departure or appointment of directors or officers; compensation", "signal": "leadership_change" } ], "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526330853/mobi-20260730.htm" }, { "filed": "2026-07-15", "items": [ { "item": "5.02", "label": "Departure or appointment of directors or officers; compensation", "signal": "leadership_change" } ], "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526304763/mobi-20260714.htm" }, { "filed": "2026-05-11", "items": [ { "item": "5.03", "label": "Amendments to articles or bylaws; change in fiscal year", "signal": "governance" }, { "item": "9.01", "label": "Financial statements and exhibits", "signal": "exhibits" } ], "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033685/mobiamedical-closing8xk.htm" } ], "insider_trades": [ { "owner": "Chase C. Leavitt", "role": "SEE REMARKS", "action": "bought", "code": "P", "shares": 2000, "value_usd": 20600, "date": "2026-09-11", "filed": "2026-09-15", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526391998/0001193125-26-391998-index.htm" }, { "owner": "Casey M. Tansey", "role": "Director", "action": "bought", "code": "P", "shares": 16441, "value_usd": 198443, "date": "2026-08-18", "filed": "2026-08-20", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526359683/0001193125-26-359683-index.htm" }, { "owner": "Casey M. Tansey", "role": "Director", "action": "bought", "code": "P", "shares": 68559, "value_usd": 797253, "date": "2026-08-17", "filed": "2026-08-17", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526354538/0001193125-26-354538-index.htm" }, { "owner": "Nelson Bunker Curnes", "role": "Chief Financial Officer", "action": "bought", "code": "P", "shares": 5000, "value_usd": 63950, "date": "2026-06-09", "filed": "2026-06-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526268109/0001193125-26-268109-index.htm" }, { "owner": "Casey M. Tansey", "role": "Director", "action": "bought", "code": "P", "shares": 66666, "value_usd": 999990, "date": "2026-05-11", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/0001628280-26-033820-index.htm" }, { "owner": "William T. Harrington", "role": "Director", "action": "bought", "code": "P", "shares": 533333, "value_usd": 7999995, "date": "2026-05-11", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033811/0001628280-26-033811-index.htm" }, { "owner": "Cynthia L. Lucchese", "role": "Director", "action": "bought", "code": "P", "shares": 125000, "value_usd": 1875000, "date": "2026-05-11", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033810/0001628280-26-033810-index.htm" }, { "owner": "Chase C. Leavitt", "role": "See Remarks", "action": "bought", "code": "P", "shares": 3000, "value_usd": 45000, "date": "2026-05-11", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033808/0001628280-26-033808-index.htm" }, { "owner": "Dana G. Mead Jr.", "role": "Director", "action": "bought", "code": "P", "shares": 7000, "value_usd": 105000, "date": "2026-05-11", "filed": "2026-05-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026033807/0001628280-26-033807-index.htm" } ], "quotes": [ { "text": "This quarter, we delivered our strongest results yet. Revenue growth of 73% reflects the strength of our commercial execution and the predictable nature of our patient funnel", "speaker": "Richard Foust", "title": "President and Chief Executive Officer of Mobia Medical", "form": "8-K", "filed": "2026-11-05", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526449807/mobi-ex99_1.htm" } ], "latest_filings": [ { "form": "8-K", "filed": "2026-08-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526344666/mobi-20260811.htm" }, { "form": "10-Q", "filed": "2026-08-11", "source_url": "https://www.sec.gov/Archives/edgar/data/1489993/000119312526344893/mobi-20260630.htm" } ], "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from." }